학술논문

Endothelin-1 mediated glycosaminoglycan synthesizing gene expression involves NOX-dependent transactivation of the transforming growth factor-[beta] receptor
Document Type
Academic Journal
Source
Molecular and Cellular Biochemistry. April, 2022, Vol. 477 Issue 4, p981, 8 p.
Subject
Tyrosine -- Health aspects -- Research
Genetic research -- Health aspects
Genes -- Research -- Health aspects
Bosentan -- Research
G proteins -- Research -- Health aspects
Oxidases -- Research -- Health aspects
RNA -- Research -- Health aspects
Transforming growth factors -- Research -- Health aspects
Bone morphogenetic proteins -- Health aspects -- Research
Thrombin -- Health aspects -- Research
Atherosclerosis -- Research
Cysteine -- Research -- Health aspects
Endothelin -- Research
Gene expression -- Research -- Health aspects
Ethylenediaminetetraacetic acid -- Research
Proteins -- Health aspects -- Research
Glycosaminoglycans -- Health aspects -- Research
Language
English
ISSN
0300-8177
Abstract
G protein-coupled receptor (GPCR) agonist endothelin-1 (ET-1) through transactivation of the transforming growth factor (TGF) [beta] receptor (TGFBR1) stimulates glycosaminoglycan (GAG) elongation on proteoglycans. GPCR agonists thrombin and lysophosphatidic acid (LPA) via respective receptors transactivate the TGFBR1 via Rho/ROCK dependent pathways however mechanistic insight for ET-1 transactivation of the TGFBR1 remains unknown. NADPH oxidase (NOX) generates reactive oxygen species (ROS) and is a signalling entity implicated in the pathogenesis of many diseases including atherosclerosis. If implicated in this pathway, NOX/ROS would be a potential therapeutic target. In this study, we investigated the involvement of NOX in ET-1/ET receptor-mediated transactivation of TGFBR1 to stimulate mRNA expression of GAG chain synthesizing enzymes chondroitin 4-O-sulfotransferase 1 (C4ST-1) and chondroitin sulfate synthase 1 (ChSy-1). The invitro model used vascular smooth muscle cells that were treated with pharmacological antagonists in the presence and absence of ET-1 or TGF-[beta]. Proteins and phosphoproteins isolated from treated cells were quantified by western blotting and quantitative real-time PCR was used to assess mRNA expression of GAG synthesizing enzymes. In the presence of diphenyliodonium (DPI) (NOX inhibitor), ET-1 stimulated phospho-Smad2C levels were inhibited. ET-1 mediated mRNA expression of GAG synthesizing enzymes C4ST-1 and ChSy-1 was also blocked by TGBFR1 antagonists, SB431542, broad spectrum ET receptor antagonist bosentan, DPI and ROS scavenger N-acetyl-l-cysteine. This work shows that NOX and ROS play an important role in ET-1 mediated transactivation of the TGFBR1 and downstream gene targets associated with GAG chain elongation. As ROS is involved in GPCR to protein tyrosine kinase receptor transactivation, the NOX/ROS axis presents as the first common biochemical target in all GPCR to kinase receptor transactivation signalling.
Author(s): Hossein Babaahmadi-Rezaei [sup.1], Peter J. Little [sup.2] [sup.3], Raafat Mohamed [sup.2], Ghorban Mohammad Zadeh [sup.1], Alireza Kheirollah [sup.4], Reyhaneh Niayesh Mehr [sup.1] [sup.5], Danielle Kamato [sup.2], Parisa Dayati [sup.1] [...]